| ■ 영문 제목 : Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00146 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 94 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 ICAD (두개내 죽상동맥경화증) 병리학의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (스텐트, PTA 기구)와 용도별 시장규모 (병원, 클리닉, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 ICAD (두개내 죽상동맥경화증) 병리학 시장 점유율 - 지역별 ICAD (두개내 죽상동맥경화증) 병리학 시장규모 - 주요지역의 종류별 시장규모 (스텐트, PTA 기구) - 주요지역의 용도별 시장규모 (병원, 클리닉, 기타) - 미주의 ICAD (두개내 죽상동맥경화증) 병리학 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 ICAD (두개내 죽상동맥경화증) 병리학 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 ICAD (두개내 죽상동맥경화증) 병리학 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 ICAD (두개내 죽상동맥경화증) 병리학 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 ICAD (두개내 죽상동맥경화증) 병리학 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Stryker, Balt, TERUMO, MicroPort, Acandis - 조사의 결과/결론 |
According to this latest study, the 2021 growth of ICAD (Intracranial Atherosclerotic Disease) Pathology will have significant change from previous year. By the most conservative estimates of global ICAD (Intracranial Atherosclerotic Disease) Pathology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 157.5 million in 2020. Over the next five years the ICAD (Intracranial Atherosclerotic Disease) Pathology market will register a 9.1% CAGR in terms of revenue, the global market size will reach US$ 223.4 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of ICAD (Intracranial Atherosclerotic Disease) Pathology market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Stent
PTA Balloon
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Stryker
Balt
TERUMO
MicroPort
Acandis
1 Scope of the Report 2 Executive Summary 3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company 4 ICAD (Intracranial Atherosclerotic Disease) Pathology by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Stent Table 3. Major Players of PTA Balloon Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2016-2021) & (Units) Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021) Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2016-2021) & ($ million) Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2016-2021) Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Type (2016-2021) Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2016-2021) & (Units) Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021) Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Application (2016-2021) Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2016-2021) Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Application (2016-2021) Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2019-2021) & (Units) Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company (2019-2021) Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2019-2021) ($ Millions) Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2019-2021) Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Company (2019-2021) Table 19. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Producing Area Distribution and Sales Area Table 20. Players ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered Table 21. ICAD (Intracranial Atherosclerotic Disease) Pathology Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2016-2021) (Units) Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2016-2021) Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2016-2021) & ($ Millions) Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2016-2021) Table 28. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units) Table 29. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021) Table 30. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021) Table 32. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2016-2021) & (Units) Table 33. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021) Table 34. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2016-2021) & (Units) Table 35. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021) Table 36. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2016-2021) & (Units) Table 37. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2016-2021) Table 38. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2016-2021) Table 40. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2016-2021) & (Units) Table 41. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021) Table 42. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2016-2021) & (Units) Table 43. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021) Table 44. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units) Table 45. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021) Table 46. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021) Table 48. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2016-2021) & (Units) Table 49. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021) Table 50. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2016-2021) & (Units) Table 51. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units) Table 53. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2016-2021) & (Units) Table 57. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2016-2021) & (Units) Table 59. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of ICAD (Intracranial Atherosclerotic Disease) Pathology Table 61. Key Application and Potential Industries of ICAD (Intracranial Atherosclerotic Disease) Pathology Table 62. Key Challenges of ICAD (Intracranial Atherosclerotic Disease) Pathology Table 63. Key Trends of ICAD (Intracranial Atherosclerotic Disease) Pathology Table 64. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List Table 65. ICAD (Intracranial Atherosclerotic Disease) Pathology Customer List Table 66. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2021-2026) & (Units) Table 67. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Forecast by Region Table 68. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2021-2026) & (Units) Table 71. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2021-2026) & (Units) Table 73. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2021-2026) & (Units) Table 75. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2021-2026) & (Units) Table 77. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2021-2026) & (Units) Table 79. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Type (2021-2026) Table 80. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Type (2021-2026) Table 82. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2021-2026) & (Units) Table 83. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Application (2021-2026) Table 84. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Application (2021-2026) Table 86. Stryker Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors Table 87. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered Table 88. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 89. Stryker Main Business Table 90. Stryker Latest Developments Table 91. Balt Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors Table 92. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered Table 93. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 94. Balt Main Business Table 95. Balt Latest Developments Table 96. TERUMO Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors Table 97. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered Table 98. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 99. TERUMO Main Business Table 100. TERUMO Latest Developments Table 101. MicroPort Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors Table 102. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered Table 103. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 104. MicroPort Main Business Table 105. MicroPort Latest Developments Table 106. Acandis Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors Table 107. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered Table 108. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 109. Acandis Main Business Table 110. Acandis Latest Developments List of Figures Figure 1. Picture of ICAD (Intracranial Atherosclerotic Disease) Pathology Figure 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2016-2026 (Units) Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Stent Figure 10. Product Picture of PTA Balloon Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2020 Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2016-2021) Figure 13. ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Hospital Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Hospital (2016-2021) & (Units) Figure 15. ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Clinic Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Clinic (2016-2021) & (Units) Figure 17. ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Other Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Other (2016-2021) & (Units) Figure 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021) Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application in 2020 Figure 21. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market by Company in 2020 ($ Million) Figure 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company in 2020 Figure 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Regions (2016-2021) Figure 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region in 2020 Figure 25. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2021 (Units) Figure 26. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2016-2021 ($ Millions) Figure 27. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2021 (Units) Figure 28. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2016-2021 ($ Millions) Figure 29. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2021 (Units) Figure 30. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2016-2021 ($ Millions) Figure 31. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2021 (Units) Figure 32. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2016-2021 ($ Millions) Figure 33. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2020 Figure 34. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2020 Figure 35. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2020 Figure 36. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2020 Figure 37. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 38. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 39. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 40. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 41. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region in 2020 Figure 42. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions in 2020 Figure 43. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2020 Figure 44. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2020 Figure 45. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 46. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 47. Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 48. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 49. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 50. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 51. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2020 Figure 52. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2020 Figure 53. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2020 Figure 54. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2020 Figure 55. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 56. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 57. UK ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 58. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 59. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 60. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2020 Figure 61. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2020 Figure 62. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2020 Figure 63. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2020 Figure 64. Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 65. South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 66. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 67. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 68. GCC Country ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2016-2021 ($ Millions) Figure 69. Channels of Distribution Figure 70. Distributors Profiles |
| ※본 조사보고서 [세계의 ICAD (두개내 죽상동맥경화증) 병리학 시장예측 2021년-2026년] (코드 : LPI-2201K00146) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 ICAD (두개내 죽상동맥경화증) 병리학 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |